Itabashi Ryo, Toyoda Kazunori, Yasaka Masahiro, Kuwashiro Takahiro, Nakagaki Hideaki, Miyashita Fumio, Okada Yasushi, Naritomi Hiroaki, Minematsu Kazuo
Cerebrovascular Division, Department of Medicine, National Cardiovascular Center, Suita, Osaka, Japan.
J Hypertens. 2008 Oct;26(10):2016-21. doi: 10.1097/HJH.0b013e32830b896d.
Blood pressure lowering in acute intracerebral hemorrhage patients may prevent hematoma growth and neurological deterioration. The optimal goal of hyperacute antihypertensive therapy for intracerebral hemorrhage patients to obtain a favorable early clinical outcome was investigated.
Of 688 consecutive patients who were admitted to our stroke care units within 24 h after intracerebral hemorrhage onset, 244 patients who emergently received intravenous antihypertensive therapy due to admission blood pressure at least 180/105 mmHg were assessed. The average systolic and diastolic blood pressure values 6, 12, and 24 h after admission and the percentage reduction of the blood pressure value with respect to the admission blood pressure value were used for analysis.
At 3 weeks, 66 patients (27%) had a completely independent activity level corresponding to a modified Rankin Scale score of 1 or less. After adjustment for baseline characteristics, a favorable functional outcome was more common in patients with the lowest quartile of average systolic blood pressure in the initial 24 h (<138 mmHg, odds ratio 4.36, 95% confidence interval 1.10-17.22), and was similarly common in those with the middle two quartiles (138-148 mmHg, 148-158 mmHg) than in those with the highest quartile of systolic blood pressure (> or = 158 mmHg). Analyses using patient quartiles on the basis of the average diastolic blood pressure or the reduction of systolic or diastolic blood pressure did not show an association with early outcome.
Lowering the systolic blood pressure to less than 138 mmHg during the initial 24 h appears to be predictive of favorable early outcome in intracerebral hemorrhage patients. Randomized controlled trials to answer this question are needed.
降低急性脑出血患者的血压可能会预防血肿扩大和神经功能恶化。本研究探讨了脑出血患者超急性期降压治疗的最佳目标,以获得良好的早期临床结局。
在脑出血发病后24小时内入住我们卒中监护病房的688例连续患者中,评估了244例因入院时血压至少为180/105 mmHg而紧急接受静脉降压治疗的患者。分析入院后6、12和24小时的平均收缩压和舒张压值,以及血压值相对于入院血压值的降低百分比。
在3周时,66例患者(27%)的活动水平完全独立,改良Rankin量表评分为1分或更低。在对基线特征进行调整后,初始24小时内平均收缩压处于最低四分位数的患者(<138 mmHg,比值比4.36,95%置信区间1.10-17.22)更常出现良好的功能结局,并且收缩压处于中间两个四分位数(138-148 mmHg,148-158 mmHg)的患者与收缩压处于最高四分位数(≥158 mmHg)的患者相比,出现良好功能结局的情况相似。基于平均舒张压或收缩压或舒张压降低情况对患者进行四分位数分析,未显示与早期结局相关。
在最初24小时内将收缩压降至低于138 mmHg似乎可预测脑出血患者的早期良好结局。需要进行随机对照试验来回答这个问题。